Identification and Validation of Apparent Imbalanced Epi-lncRNAs Prognostic Model Based on Multi-Omics Data in Pancreatic Cancer

Overview

Journal Front Mol Biosci

Specialty Biology

Date 2022 Jun 1

PMID 35647035

Authors

Mujing Ke

Affiliations

Soon will be listed here.

Abstract

Globally, pancreatic adenocarcinoma is a recognized cause of pancreatic death (PAAD) associated with high mortality. Long non-coding RNAs (lncRNAs) play an important role in several biological processes in pancreatic cancer. The gene expression profile of PAAD patients were obtained from The Cancer Genome Atlas (TCGA) database. The package was used to identify epigenetic disorders of lncRNAs and PCG. Subsequently, the genomic characteristics and landscape of lncRNAs were explored. The pancreatic cancer-related lncRNAs gene set from Lnc2Cancer v3.0 were collected and the difference between cancer samples and normal samples were analysed. A prognostic model consisting of five epigenetic lncRNA (epi-lncRNAs) was established by univariate and multivariate Cox proportional hazards regression analyses and was verified across different data sets. Finally, the expression of core epi-lncRNAs was identified by PCR experiment. A total of 2237 epi-lncRNAs, 11855 non-epi-lncRNAs, 13518 epi-PCGs, and 6097 non-epi-PCGs, were identified. The abnormal frequency of lncRNAs in pancreatic cancer was much lower than that in PCG, and 138 epi-lncRNAs were enriched in human cancer-related lncRNAs. Epi-lncRNAs had a higher number with longer lengths and a greater number of transcripts. Epi-lncRNAs associated with epigenetic disorders had a higher number of exons, gene length, and isomers as compared to non-epi-lncRNAs. Further, the five pancreatic cancer-specific epi-lncRNA genes (AL161431.1, LINC00663, LINC00941, SNHG10, and TM4SF1-AS1) were identified. Based on these five pancreatic cancer-specific epis-lncRNAs, a prognostic model for pancreatic cancer was established. The RT-PCR result confirmed that AL161431.1, LINC00663, LINC00941, and SNHG10 expressions in pancreatic cancer samples were higher as compared to normal pancreatic samples; the expression of TM4SF1-AS1 in pancreatic cancer cells was significantly lower than that in normal pancreatic samples. Epigenetic abnormalities could promote abnormal lncRNA expression in pancreatic cancer and may play an important role in its progression.

Citing Articles

Comprehensive multi-omics profiling identifies novel molecular subtypes of pancreatic ductal adenocarcinoma.

Wang X, Yang J, Ren B, Yang G, Liu X, Xiao R Genes Dis. 2024; 11(6):101143.

PMID: 39253579 PMC: 11382047. DOI: 10.1016/j.gendis.2023.101143.

Silencing LINC00663 inhibits inflammation and angiogenesis through downregulation of NR2F1 via EBF1 in bladder cancer.

Zhong X, Sun L, Liu J, Yang X, Hou M, Wang X RNA Biol. 2024; 21(1):9-22.

PMID: 39219375 PMC: 11188801. DOI: 10.1080/15476286.2024.2368304.

Signature identification based on immunogenic cell death-related lncRNAs to predict the prognosis and immune activity of patients with endometrial carcinoma.

Yao Y, Zhang Q, Wei S, Li H, Zhou T, Zhang Q Transl Cancer Res. 2024; 13(6):2913-2937.

PMID: 38988945 PMC: 11231768. DOI: 10.21037/tcr-23-2243.

The prognostic value of sialylation-related long non-coding RNAs in lung adenocarcinoma.

Wang B, Hou C, Yu X, Liu J, Wang J Sci Rep. 2024; 14(1):8879.

PMID: 38632255 PMC: 11024174. DOI: 10.1038/s41598-024-59130-3.

LncRNA-MUF: A Novel Oncogenic Star with Potential as a Biological Marker and Therapeutic Target for Gastrointestinal Malignancies.

Wang Y, Wang J, Zhang Y, Luo H, Yuan H J Cancer. 2024; 15(6):1498-1510.

PMID: 38370364 PMC: 10869981. DOI: 10.7150/jca.91984.

References

Locker G, Hamilton S, Harris J, Jessup J, Kemeny N, Macdonald J . ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006; 24(33):5313-27. DOI: 10.1200/JCO.2006.08.2644. View

Ren M, Chen S, Wang L, Rui W, Li P . LINC00941 Promotes Progression of Non-Small Cell Lung Cancer by Sponging miR-877-3p to Regulate VEGFA Expression. Front Oncol. 2021; 11:650037. PMC: 8044452. DOI: 10.3389/fonc.2021.650037. View

Li C, Zhou L, He J, Fang X, Zhu S, Xiong M . Increased long noncoding RNA SNHG20 predicts poor prognosis in colorectal cancer. BMC Cancer. 2016; 16:655. PMC: 4992210. DOI: 10.1186/s12885-016-2719-x. View

Jaenisch R, Bird A . Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003; 33 Suppl:245-54. DOI: 10.1038/ng1089. View

Zhou M, Diao Z, Yue X, Chen Y, Zhao H, Cheng L . Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer. Oncotarget. 2016; 7(35):56383-56394. PMC: 5302921. DOI: 10.18632/oncotarget.10891. View

Gujar H, Weisenberger D, Liang G . The Roles of Human DNA Methyltransferases and Their Isoforms in Shaping the Epigenome. Genes (Basel). 2019; 10(2). PMC: 6409524. DOI: 10.3390/genes10020172. View

McDaniel S, Hepperla A, Huang J, Dronamraju R, Adams A, Kulkarni V . H3K36 Methylation Regulates Nutrient Stress Response in Saccharomyces cerevisiae by Enforcing Transcriptional Fidelity. Cell Rep. 2017; 19(11):2371-2382. PMC: 5528882. DOI: 10.1016/j.celrep.2017.05.057. View

OBrien D, Sandanayake N, Jenkinson C, Gentry-Maharaj A, Apostolidou S, Fourkala E . Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection. Clin Cancer Res. 2014; 21(3):622-31. PMC: 4181906. DOI: 10.1158/1078-0432.CCR-14-0365. View

Luo G, Zhang Y, Guo P, Ji H, Xiao Y, Li K . Global Patterns and Trends in Pancreatic Cancer Incidence: Age, Period, and Birth Cohort Analysis. Pancreas. 2018; 48(2):199-208. DOI: 10.1097/MPA.0000000000001230. View

10.

Nizovtseva E, Todolli S, Olson W, Studitsky V . Towards quantitative analysis of gene regulation by enhancers. Epigenomics. 2017; 9(9):1219-1231. PMC: 5585842. DOI: 10.2217/epi-2017-0061. View

11.

Liang M, Wang L, Cao C, Song S, Wu F . LncRNA SNHG10 is downregulated in non-small cell lung cancer and predicts poor survival. BMC Pulm Med. 2020; 20(1):273. PMC: 7574240. DOI: 10.1186/s12890-020-01281-w. View

12.

Gen Y, Muramatsu T, Inoue J, Inazawa J . miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4. Cancer Res. 2021; 81(20):5190-5201. DOI: 10.1158/0008-5472.CAN-21-0649. View

13.

Cheng W, Tao H, Hu E, Liu S, Cai H, Tao X . Both genes and lncRNAs can be used as biomarkers of prostate cancer by using high throughput sequencing data. Eur Rev Med Pharmacol Sci. 2014; 18(22):3504-10. View

14.

Tay Y, Rinn J, Pandolfi P . The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014; 505(7483):344-52. PMC: 4113481. DOI: 10.1038/nature12986. View

15.

Li Z, Jiang P, Li J, Peng M, Zhao X, Zhang X . Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma. Oncogene. 2018; 37(28):3822-3838. DOI: 10.1038/s41388-018-0237-9. View

16.

Fu Z, Li G, Li Z, Wang Y, Zhao Y, Zheng S . Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells. Cell Death Discov. 2017; 3:17004. PMC: 5447127. DOI: 10.1038/cddiscovery.2017.4. View

17.

Orth M, Metzger P, Gerum S, Mayerle J, Schneider G, Belka C . Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. Radiat Oncol. 2019; 14(1):141. PMC: 6688256. DOI: 10.1186/s13014-019-1345-6. View

18.

Li J, Wang X, Tang J, Jiang R, Zhang W, Ji J . HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma. Cell Physiol Biochem. 2015; 37(2):687-96. DOI: 10.1159/000430387. View

19.

Tesfaye A, Kamgar M, Azmi A, Philip P . The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities. Expert Rev Anticancer Ther. 2017; 18(2):131-148. PMC: 6121777. DOI: 10.1080/14737140.2018.1417844. View

20.

Zhang B, Jin Z, Zhang H . LINC01207 promotes the progression of non-small cell lung cancer via regulating ARHGAP11A by sponging miR-525-5p. Cancer Biomark. 2021; 33(3):401-414. DOI: 10.3233/CBM-203197. View